News and views
May 2012 Br J Cardiol 2012;19:62–3
“You want it by when?”
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab… and beyond. In this column, he muses on deadlines upcoming and gone....
May 2012 Br J Cardiol 2012;19:56
Introductory cardiovascular magnetic resonance
Society for Cardiovascular Magnetic Resonance Cardiovascular magnetic resonance (CMR) is playing an increasing role in the diagnosis and classification of heart disease, with as many as one in seven diagnoses changed when scrutinised using CMR. Accordingly, the Cardiology Curriculum requires trainees to observe and report 50 CMR cases, which can be challenging given the current availability of CMR....
May 2012 Br J Cardiol 2012;19:89
Book review
Ultrasound in clinical diagnosis. From pioneering developments in Lund to global application in medicine Editors: Eklöf B, Lindström K, Persson S Publisher: Oxford University Press, Oxford, 2011 ISBN: 978-0-960207-0 Price: £75...
March 2012 Br J Cardiol 2012;19:15
Correspondence: Chest pain
Correspondence from the world of cardiology....
March 2012 Br J Cardiol 2012;19:9
Primary Care Cardiovascular Society announces closure
The British Journal of Cardiology is sorry to report the closure of the Primary Care Cardiovascular Society (PCCS), which ceased operating at on the 31st of January 2012. The BJC has been the society's official journal....
March 2012 Br J Cardiol 2012;19:10
MI deaths continue to fall sharply in England
The death rate from heart attacks in England halved in the eight years between 2002 and 2010, new data show....
March 2012 Br J Cardiol 2012;19:10
Aspirin in primary prevention: new meta-analysis
A new meta-analysis has shown that cardiovascular benefits of aspirin in the primary prevention population are balanced by the risk of bleeding. ...
March 2012 Br J Cardiol 2012;19:10
TRA-2P: new antiplatelet drug reduces CV events but ups bleeding
Top-line results of the TRA-2P study have shown that Merck’s novel antiplatelet agent, vorapaxar, reduced the primary ischaemic end point of the study, but increased bleeding, including intracranial haemorrhage in a secondary prevention population. ...
March 2012 Br J Cardiol 2012;19:11
Statins associated with increased risk of diabetes
More concern about the risk of diabetes with statins has been voiced after new data from the Women’s Health Initiative (WHI) has shown a 48% increased risk of diabetes in post-menopausal women taking these agents in the study. This adds to results of two meta-analyses of statin studies published recently, which also suggested a significant increase in risk of diabetes with statins. ...
March 2012 Br J Cardiol 2012;19:11
Telehealth rollout to accelerate
Prime Minister, David Cameron, has announced that telecare and telehealth systems will be rolled out to the homes of three million people over the next five years as part of the “3 Million Lives” campaign, aiming to improve patient care and reduce costs. ...
